Prospective Evaluation of the Prediction Score for a Mild Course of Crohn’s Disease (PreMiCC) in Newly Diagnosed Patients With Crohn’s Disease: The PROGNOS Study
Inflammatory Bowel Diseases · 03.03.2025 · 31 (3) · 677-685
DOI: 10.1093/ibd/izae086 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 22.04.2024. Verfasst von Wolfgang Kruis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Protestant Hospital, Cologne, Germany. Hauptthemen laut MEDLINE: Crohn Disease, Severity of Illness Index. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ferring Arzneimittel GmbH Kiel, Germany.
Abstract (Originalsprache)
Background and Aims The course of Crohn’s disease (CD) is highly variable. The Prospektive Evaluation eines Score zur Vorhersage eines milden Verlaufsbei neu diagnostizierten Morbus Crohn-Patienten in gastroenterologischen Fachpraxen (PROGNOS) study aimed to determine the frequency of a mild disease course and validate a proposed prediction score.
Methods
The PROGNOS study is a prospective study of CD patients who were newly diagnosed and, except for 1 course of 5-aminosalicylic acid or steroids for ≤10 days, therapy-naïve. Among other predefined inclusion criteria, the initial diagnosis had to be made ≤6 weeks before enrollment. All inception cohort patients were diagnosed and screened consecutively in participating gastroenterology practices in Germany specialized in inflammatory bowel disease. All screened CD patients were scored and, if possible, included in the study for up to 5 years (NCT02193048).
Results
A total of 201 CD patients were included in the study (43.3% male; mean age 33 years, mean follow-up 38 months). Altogether, 29.5% of the patients had a mild course at 36 months. Among those with a score ≤2, therapy escalation at 36 months was necessary for only 24.2%, whereas in the group with a score >2, therapy escalation was necessary for 70.2% of patients. In the Kaplan-Meier curve showing time to therapy escalation in the 2 groups, there was a pronounced and statistically significant divergence of the curves starting at 3 months and extending to 48 months (P < .001).
Conclusions
In this prospective study, about 30% of incident CD patients had a mild disease course. Our suggested PreMiCC (prediction score for a mild course of Crohn’s disease) successfully predicted this.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Protestant Hospital, Cologne, Germany.
- Department of Internal Medicine, Interdisciplinary Crohn Colitis Centre, Minden, Germany.
- Clinic of General Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
- Gastroenterology Practice, Kiel-Altenholz, Germany.
- Gastroenterology Practice Clinic, Nuremberg, Germany.
- Gastroenterology Practice, Berlin, Germany.
ORCID-Profile: Bernd Bokemeyer
Förderung
- Ferring Arzneimittel GmbH Kiel, Germany
Zitieren
APA
Kruis, W., Bokemeyer, B., Jessen, P., Hoesl, M., Mroß, M., Morgenstern, J., Reimers, B., Müller-Grage, N., & Leifeld, L. (2025). Prospective Evaluation of the Prediction Score for a Mild Course of Crohn’s Disease (PreMiCC) in Newly Diagnosed Patients With Crohn’s Disease: The PROGNOS Study. Inflammatory Bowel Diseases, 31(3), 677-685. https://doi.org/10.1093/ibd/izae086
Vancouver
Kruis W, Bokemeyer B, Jessen P, Hoesl M, Mroß M, Morgenstern J, et al. Prospective Evaluation of the Prediction Score for a Mild Course of Crohn’s Disease (PreMiCC) in Newly Diagnosed Patients With Crohn’s Disease: The PROGNOS Study. Inflammatory Bowel Diseases. 2025;31(3):677-685. doi:10.1093/ibd/izae086
BibTeX
@article{Kruis2025,
author = {Kruis, Wolfgang and Bokemeyer, Bernd and Jessen, Petra and Hoesl, Mark and Mroß, Michael and Morgenstern, Julia and Reimers, Birgitta and Müller-Grage, Nike and Leifeld, Ludger},
title = {Prospective Evaluation of the Prediction Score for a Mild Course of Crohn’s Disease (PreMiCC) in Newly Diagnosed Patients With Crohn’s Disease: The PROGNOS Study},
journal = {Inflammatory Bowel Diseases},
year = {2025},
volume = {31},
number = {3},
pages = {677--685},
doi = {10.1093/ibd/izae086}
}
EUVIMED